165 related articles for article (PubMed ID: 23235285)
1. Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease.
Sztanek F; Seres I; Harangi M; Lőcsey L; Koncsos P; Paragh G
Kidney Blood Press Res; 2012; 36(1):310-9. PubMed ID: 23235285
[TBL] [Abstract][Full Text] [Related]
2. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
Sztanek F; Seres I; Harangi M; Lőcsey L; Padra J; Paragh GJ; Asztalos L; Paragh G
Nephrol Dial Transplant; 2012 Jul; 27(7):2866-72. PubMed ID: 22247228
[TBL] [Abstract][Full Text] [Related]
3. Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.
Koncsos P; Seres I; Harangi M; Illyés I; Józsa L; Gönczi F; Bajnok L; Paragh G
Pediatr Res; 2010 Mar; 67(3):309-13. PubMed ID: 19915520
[TBL] [Abstract][Full Text] [Related]
4. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW
Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020
[TBL] [Abstract][Full Text] [Related]
6. Main determinants of PON1 activity in hemodialysis patients.
Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
[TBL] [Abstract][Full Text] [Related]
7. Associations of adiponectin with paraoxonase 1 and sE-selectin in hemodialyzed patients.
Peti A; Csiky B; Guth E; Kenyeres P; Varga Z; Seres I; Jeney Z; Juhasz M; Mezosi E; Paragh G; Kovacs GL; Bajnok L
Kidney Blood Press Res; 2009; 32(5):360-5. PubMed ID: 19887823
[TBL] [Abstract][Full Text] [Related]
8. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: is there a relationship?
Dervisoglu E; Eraldemir C; Kalender B; Kir HM; Caglayan C
J Ren Nutr; 2008 Jul; 18(4):332-7. PubMed ID: 18558297
[TBL] [Abstract][Full Text] [Related]
9. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
[TBL] [Abstract][Full Text] [Related]
10. Body composition in patients on haemodialysis: relationship between the type of haemodialysis and inflammatory and nutritional parameters.
Gallar-Ruiz P; Digioia C; Lacalle C; Rodríguez-Villareal I; Laso-Laso N; Hinostroza-Yanahuaya J; Oliet-Pala A; Herrero-Berron JC; Ortega-Marcos O; Ortiz-Libreros M; Mon-Mon C; Cobo-Jaramillo G; Vigil-Medina A
Nefrologia; 2012 Jul; 32(4):467-76. PubMed ID: 22806281
[TBL] [Abstract][Full Text] [Related]
11. Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients.
Varga Z; Paragh G; Seres I; Kakuk G; Karanyi Z; Karpati I; Matyus J; Csongradi E; Juhasz A; Balla J; Bajnok L
Nephron Clin Pract; 2006; 103(3):c114-20. PubMed ID: 16534235
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
Saeed SA; Elsharkawy M; Elsaeed K; Fooda O
Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients.
Locsey L; Seres I; Sztanek F; Harangi M; Padra J; Kovacs D; Fedor R; Asztalos L; Paragh G
Transplant Proc; 2013; 45(10):3685-7. PubMed ID: 24314997
[TBL] [Abstract][Full Text] [Related]
15. Effects of renal-specific oral supplementation in malnourished hemodialysis patients.
Małgorzewicz S; Rutkowski P; Jankowska M; Dębska-Ślizień A; Rutkowski B; Łysiak-Szydłowska W
J Ren Nutr; 2011 Jul; 21(4):347-53. PubMed ID: 20833074
[TBL] [Abstract][Full Text] [Related]
16. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis.
Gugliucci A; Kinugasa E; Kotani K; Caccavello R; Kimura S
Clin Chem Lab Med; 2011 Jan; 49(1):61-7. PubMed ID: 20961187
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
[TBL] [Abstract][Full Text] [Related]
19. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease--a follow-up study.
Ignacy W; Chudek J; Adamczak M; Funahashi T; Matsuzawa Y; Kokot F; Wiecek A
Nephron Clin Pract; 2005; 101(1):c18-24. PubMed ID: 15886491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
